Axokine (Regeneron).

@article{Preti2003Axokine,
  title={Axokine (Regeneron).},
  author={Antonio Preti},
  journal={IDrugs : the investigational drugs journal},
  year={2003},
  volume={6 7},
  pages={
          696-701
        }
}
Axokine, a second-generation neurotrophic factor that is related to ciliary neurotrophic factor (CNTF), is under development by Regeneron for the potential treatment of obesity and associated complications such as type 2 diabetes.